| | |
| | |
Stat |
Members: 3643 Articles: 2'487'895 Articles rated: 2609
28 March 2024 |
|
| | | |
|
Article overview
| |
|
Inhibition of noradrenaline release by antibodies to B-50 (GAP-43) | L V Dekker
; P N De Graan
; A B Oestreicher
; D H Versteeg
; W H Gispen
; | Date: |
2 Nov 1989 | Journal: | Nature, 342 (6245), 74-6 | Abstract: | Protein kinase C (PKC) is believed to have a crucial role in synaptic transmitter release and long-term potentiation. An important substrate of PKC in the brain is the neuron-specific presynaptically localized protein B-50 (also termed GAP-43, F1, pp46 or P-57). B-50 has been implicated in the regulation of polyphosphoinositide metabolism and calmodulin binding, and in the mechanisms of neurite outgrowth, long-term potentiation and transmitter release. It is still unknown, however, whether B-50 (and/or its phosphorylation) is essential to any of these processes. Here we report the results of studies in which antibodies to B-50, which interfere with B-50 phosphorylation, were introduced into rat cortical synaptosomes that were permeabilized with streptolysin-O (SL-O). We found that the release of [3H]noradrenaline, induced by increasing the Ca2+ concentration in the buffer, is inhibited completely by the antibodies. These results provide the first demonstration of a causal relationship between the PKC substrate B-50 and the release of neurotransmitter. | Source: | PubMed, pmid2812003 doi: 10.1038/342074a0 | Services: | Forum | Review | Favorites |
|
|
No review found.
Did you like this article?
Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.
browser claudebot
|
| |
|
|
|
| News, job offers and information for researchers and scientists:
| |